Back to Search
Start Over
A myocardialis necrosis mértékének vizsgálata eltérő supraventricularis szívritmuszavarok rádiófrekvenciás katéterablatiós kezelését követően
- Source :
- Orvosi Hetilap. 160:540-548
- Publication Year :
- 2019
- Publisher :
- Akademiai Kiado Zrt., 2019.
-
Abstract
- Abstract: Introduction: Levels of cardiac necroenzymes, high-sensitive troponin (hsTnT) and creatine kinase muscle-brain (CKMB) increase as a result of a myocardial damage following catheter ablation. Aim: To analyze the mid-term alteration of hsTnT and CKMB levels following radiofrequency ablation (RFCA) for atrial fibrillation (AF), atrial flutter (AFlu), AV-nodal reentry tachycardia (AVNRT) and electrophysiological studies (EPS) without ablation. Method: Patients undergoing RFCA for various indications and EPS were consecutively enrolled in our prospective study. Concentrations of hsTnT and CKMB were measured from serial blood samples directly before and after the procedure, 4 and 20 hours later and at 3 months follow-up. Results: Forty-seven patients (10 EPS, 12 AVNRT, 13 AFlu, 12 AF) with mean age of 55 ± 13 were included. hsTnT levels increased significantly in all groups after the procedures, while CKMB changed only in the AF group. hsTnT exceeded the reference value in all patients with ablation and in 80% of patients with EPS 4 hours post-ablation. Peak average hsTnT levels for EPS, AVNRT, AFlu were 24 ± 11, 260 ± 218 and 541 ± 233 ng/L, respectively. The highest hsTnT level was measured in the AF group (799 ± 433 ng/L). We found a positive correlation between hsTnT levels and ablation time after RFCA. Conclusions: The hsTnT levels significantly change after EPS and RFCA, in all patients who underwent ablation, and in 80% of those with EPS had hsTnT positivity in the early post-procedural phase. hsTnT levels depended significantly on the type of the subgroups and correlated with the ablation time. Awareness of those observations is essential to correctly interpret elevated hsTnT levels following RFCA. Orv Hetil. 2019; 160(14): 540–548.
- Subjects :
- Tachycardia
medicine.medical_specialty
biology
Radiofrequency ablation
business.industry
medicine.medical_treatment
Atrial fibrillation
Catheter ablation
General Medicine
medicine.disease
Troponin
law.invention
03 medical and health sciences
0302 clinical medicine
law
Internal medicine
biology.protein
medicine
Cardiology
030211 gastroenterology & hepatology
Creatine kinase
medicine.symptom
business
Prospective cohort study
Atrial flutter
Subjects
Details
- ISSN :
- 17886120 and 00306002
- Volume :
- 160
- Database :
- OpenAIRE
- Journal :
- Orvosi Hetilap
- Accession number :
- edsair.doi...........770ac25844e2f5016c8c54aa1b0fc67c
- Full Text :
- https://doi.org/10.1556/650.2019.31336